Better omega-3 to omega-6 ratio could cut prostate cancer risk
Increasing omega-3 fatty acid levels, and decreasing levels of omega-6, could reduce the risk of prostate cancer, if results from an animal study also apply to humans.
Increasing omega-3 fatty acid levels, and decreasing levels of omega-6, could reduce the risk of prostate cancer, if results from an animal study also apply to humans.
Heat treatments used to kill harmful bacteria in soymilk may be damaging the healthy compounds found in the beverage, according to a Chinese scientist.
UK scientists are mid-way through a project in collaboration with Ribena maker GlaxoSmithKline to boost vitamin C levels in blackcurrants, and results to date indicate it will yield benefits for consumer health, as well as the country's fruit farmers.
A promising laboratory study into the preventative action of Nexrutine from Phellodendron tree bark on prostate cancer could open up new avenues of commercialization for its formulator Next Pharmaceuticals.
Industry giants are locked in a "fish oil arms race" to develop genetically modified crops that could challenge the supremacy of fish as the best source of omega-3 fatty acid, with both BASF and DuPont reporting progress in the field.
Lignan focus
In the past 18 months, consumer awareness of plant lignans and their human metabolites has grown with media coverage of studies proposing health benefits. But where does the science stand at present?
Florida-based Neptune Industries is taking steps towards patent protection and commercialization of the technology behind a protein-based nutritional component that it says may one day prove useful in supplying third world countries with a reliable...
Supplement associations across ASEAN countries have joined forces with the formation of the ASEAN Alliance of Heath Supplement Associations (AAHSA), which aims to facilitate industry input into harmonized regulation currently in the works for the region.
The FDA has responded to criticisms made by the Union of Concerned Scientists (UCS) that the regulation body is under pressure to exclude or alter technical information on scientific reports that could affect the safety of products.